Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The overactive bladder.

Literature DB >> 11446871

The overactive bladder.

J J Wyndaele¹.

Abstract

Entities: Disease

Mesh：

Substances：
Muscarinic Agonists

Year: 2001 PMID： 11446871 DOI： 10.1046/j.1464-410x.2001.02296.x

Source DB: PubMed Journal: BJU Int ISSN： 1464-4096 Impact factor: 5.588

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. M(3) muscarinic receptors mediate contraction of human urinary bladder.

Authors: Charlotte Fetscher; Marina Fleichman; Martina Schmidt; Susanne Krege; Martin C Michel
Journal: Br J Pharmacol Date: 2002-07 Impact factor: 8.739

Review 2. Pathophysiology of overactive bladder.

Authors: Mai A Banakhar; Tariq F Al-Shaiji; Magdy M Hassouna
Journal: Int Urogynecol J Date: 2012-02-07 Impact factor: 2.894

3. Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder.

Authors: Norman Zinner; John Tuttle; Leonard Marks
Journal: World J Urol Date: 2005-11-08 Impact factor: 4.226

4. Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder.

Authors: Tim Schneider; Peter Hein; Martina B Michel-Reher; Martin C Michel
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2005-07-30 Impact factor: 3.000

5. Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder: differential regulation of M2 and M3 receptors?

Authors: Christian Kories; Claudia Czyborra; Charlotte Fetscher; Tim Schneider; Susanne Krege; Martin C Michel
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2003-03-28 Impact factor: 3.000

The overactive bladder.

1. M(3) muscarinic receptors mediate contraction of human urinary bladder.

Review 2. Pathophysiology of overactive bladder.

3. Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder.

4. Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder.

5. Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder: differential regulation of M2 and M3 receptors?

6. Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle.

Review 7. A benefit-risk assessment of extended-release oxybutynin.

8. Extracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction.

9. Overactive bladder, differential diagnosis, and clinical utility of fesoterodine.